Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05416424 · ClinicalTrials.gov registry record · NA
Life Study: Lifestyle Intervention in Fibroid Elimination
A NA study of Uterine Fibroid, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05416424 is a NA study of Uterine Fibroid that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 302-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05416424, a NA study of Uterine Fibroid, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate a lifestyle, nutrition, and exercise program to assess whether this program is acceptable and feasible for patients..Researchers will examine if the LIFE program can modify fibroid recurrence.
Conditions Studied
Interventions
- OTHER LIFE program
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-05-23 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05416424
The ClinicalTrials.gov registry entry for NCT05416424 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (67% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Fibroid appearing as the primary indexed condition, and to 1 intervention - of which LIFE program is the first listed.
NCT05416424 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05416424 about?
NCT05416424 is a clinical study titled "Life Study: Lifestyle Intervention in Fibroid Elimination". The study will evaluate a lifestyle, nutrition, and exercise program to assess whether this program is acceptable and feasible for patients..Researchers will examine if the LIFE program can modify fibroid recurrence.
What is the current status of trial NCT05416424?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-05-23. Estimated completion is 2027-01.
What conditions does trial NCT05416424 study?
This clinical trial studies the following conditions: Uterine Fibroid.
What interventions are being tested in trial NCT05416424?
The interventions under investigation include: LIFE program (OTHER).
Who is sponsoring clinical trial NCT05416424?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05416424 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings
COMPLETED · NA
-
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
RECRUITING
-
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
RECRUITING · Phase 2
-
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
COMPLETED · Phase 3
-
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.